Performance of a revised glucose method on the Dade Behring Dimension® clinical chemistry system.

被引:0
|
作者
Amsel, L [1 ]
Crawford, S [1 ]
Cybulski, R [1 ]
机构
[1] Dade Behring Inc, Newark, DE USA
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:A74 / A74
页数:1
相关论文
共 50 条
  • [31] Performance of a no-pretreatment tacrolimus assay on the Dade Behring Dimension RxL clinical chemistry analyzer
    Griffey, Megan A.
    Hock, Karl G.
    Kilgore, Daniel C.
    Wei, Tie Q.
    Duh, Show-Hong
    Christenson, Robert
    Scott, Mitchell G.
    CLINICA CHIMICA ACTA, 2007, 384 (1-2) : 48 - 51
  • [32] Establishment of reference intervals for a new myeloperoxidase assay for the dade behring Dimension® clinical chemistry system
    Morris, G. P.
    Hock, K. G.
    Figgs, T. R.
    Scott, M. G.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A15 - A15
  • [33] Evaluation of an automated, no pre-treatment hemoglobin A1c assay on the Dade Behring Dimension® clinical chemistry system.
    Terrell, AR
    Hock, KG
    Ruttle, D
    Cervelli, DR
    Scott, MG
    CLINICAL CHEMISTRY, 2002, 48 (06) : A37 - A38
  • [34] Myeloperoxidase:: A potential new addition to the cardiac panel on the Dade Behring Dimension® Clinical Chemistry System
    Duggan, L. J.
    Bedzyk, W.
    Briggs, C.
    Desai, V.
    Sharma, M.
    Singh, P.
    Bauer, R.
    CLINICAL CHEMISTRY, 2006, 52 (06) : A126 - A126
  • [35] Development of an automated immunoassay for NT-proBNP on the Dade Behring Dimension® clinical chemistry system
    Wei, T
    Tuhy, P
    Bantum, L
    Posey, A
    Miller, L
    Singh, P
    Duffy, J
    Pierson-Perry, J
    CLINICAL CHEMISTRY, 2004, 50 (06) : A13 - A14
  • [36] Analytical and clinical performance of the NT-proBNP assay on the Dade Behring Dimension® clinical chemistry system and the Stratus® CSSTAT Fluorometric Analyzer
    Christenson, RH
    Scott, MG
    Hock, KG
    Jones, HL
    Figgs, TR
    CLINICAL CHEMISTRY, 2005, 51 : A19 - A20
  • [37] Measurement of tobramycin, gentamicin and vancomycin on the Dade Dimension(R) Clinical Chemistry System.
    Tuggey, RL
    Brown, CB
    Moses, K
    Braun, A
    Johnson, AL
    Mayer, TK
    CLINICAL CHEMISTRY, 1997, 43 : 483 - 483
  • [38] Performance characteristics of Prostate Specific Antigen (PSA) on the Dade Dimension(R) RxL clinical chemistry system.
    Ballas, RA
    Amsel, LM
    Zhao, WG
    Demers, LM
    Walsh, P
    Freehafer, SV
    CLINICAL CHEMISTRY, 1997, 43 : 584 - 584
  • [39] An application for Emit® caffeine, amikacin and methotrexate assays on the dade behring Dimension® RxL MaxTM clinical chemistry system
    Mendu, D.
    Chou, P. P.
    Soldin, S. J.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A70 - A70
  • [40] Development and performance of a free T4 method for the Dade Behring aca® plus immunoassay system.
    Pierson-Perry, J
    Larson, L
    Tuhy, P
    Waller, S
    Kamm, C
    Vance, S
    Branham, E
    Wierwille, S
    Meeks, G
    CLINICAL CHEMISTRY, 1998, 44 : A149 - A149